Print

Purpose

The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 13 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Conditions

Eligibility

Eligible Ages
Between 13 Years and 64 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age 13 through 64 years - Diagnosed with COVID-19 at least 2 months prior enrollment - Patients with or without obesity, diabetes, chronic fatigue and/or long term COVID-19 symptoms - Patients without COVID-19 diagnosis for controls

Exclusion Criteria

  • Received the influenza vaccine less than 4 months ago - Pregnant or lactating - Patients with special risks attendant to venipuncture - Use of immunomodulatory medications - Immunodeficiency or autoimmune disease

Study Design

Phase
Study Type
Observational
Observational Model
Case-Control
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
COVID-19 participants
  • Biological: Flu shot
    All participants will receive a single shot of the flu vaccine
Control participants
  • Biological: Flu shot
    All participants will receive a single shot of the flu vaccine

Recruiting Locations

Stanford University
Palo Alto, California 94304
Contact:
SNP Center Inquiry
(650) 521-7237
snpcenterallergy_inquiry@stanford.edu

More Details

NCT ID
NCT04579588
Status
Recruiting
Sponsor
Stanford University

Study Contact

SNP Center Inquiry
(650) 521-7237
snpcenterallergy_inquiry@stanford.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.